- Home
- CLRB vs SMTK Comparison
CLRB vs SMTK Comparison
Compare CLRB & SMTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLRB
- SMTK
- Stock Information
- Founded
- CLRB 2002
- SMTK 2009
- Country
- CLRB United States
- SMTK United Kingdom
- Employees
- CLRB N/A
- SMTK N/A
- Industry
- CLRB Biotechnology: Pharmaceutical Preparations
- SMTK
- Sector
- CLRB Health Care
- SMTK
- Exchange
- CLRB Nasdaq
- SMTK NYSE
- Market Cap
- CLRB 10.7M
- SMTK 13.3M
- IPO Year
- CLRB N/A
- SMTK N/A
- Fundamental
- Price
- CLRB $0.24
- SMTK $3.72
- Analyst Decision
- CLRB Buy
- SMTK
- Analyst Count
- CLRB 2
- SMTK 0
- Target Price
- CLRB $28.00
- SMTK N/A
- AVG Volume (30 Days)
- CLRB 3.3M
- SMTK 109.9K
- Earning Date
- CLRB 11-18-2024
- SMTK 02-12-2025
- Dividend Yield
- CLRB N/A
- SMTK N/A
- EPS Growth
- CLRB N/A
- SMTK N/A
- EPS
- CLRB N/A
- SMTK N/A
- Revenue
- CLRB N/A
- SMTK $40,000.00
- Revenue This Year
- CLRB N/A
- SMTK N/A
- Revenue Next Year
- CLRB N/A
- SMTK N/A
- P/E Ratio
- CLRB N/A
- SMTK N/A
- Revenue Growth
- CLRB N/A
- SMTK 471.43
- 52 Week Low
- CLRB $0.22
- SMTK $2.01
- 52 Week High
- CLRB $4.45
- SMTK $13.00
- Technical
- Relative Strength Index (RSI)
- CLRB 18.75
- SMTK N/A
- Support Level
- CLRB $0.27
- SMTK N/A
- Resistance Level
- CLRB $0.33
- SMTK N/A
- Average True Range (ATR)
- CLRB 0.03
- SMTK 0.00
- MACD
- CLRB 0.05
- SMTK 0.00
- Stochastic Oscillator
- CLRB 10.38
- SMTK 0.00
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. Its PDC therapeutic, iopofosine is a small-molecule PDC designed to provide targeted delivery of iodine-131 directly to cancer cells, while limiting exposure to healthy cells.
About SMTK SMARTKEM INC
SmartKem Inc focuses on the design, development, industrialization, and technology transfer of low-temperature, solution-deposited organic semiconductors for transistor backplanes. The company's semiconductor platform can be used in a number of applications including mini-LED displays, AMOLED displays, fingerprint sensors, and logic circuits. The company derives revenue from the sale of TRUFLEX inks and demonstration products.